DLL3 and prostate cancer: In terms of prostate cancer, Oktem and colleagues identified CD133high/CD44high DU145 prostate CSCs and found that Jagged1, Delta-like 3, and Notch-1 were respectively upregulated genes in the Notch signaling pathway appearing to be due to malignancy and tumor progression [19].